Skip to main content
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
5.96
+0.08 (1.45%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Champions Oncology Revenue

Champions Oncology had revenue of $15.04M in the quarter ending October 31, 2025, with 11.46% growth. This brings the company's revenue in the last twelve months to $58.42M, up 9.06% year-over-year. In the fiscal year ending April 30, 2025, Champions Oncology had annual revenue of $56.94M with 13.54% growth.

Revenue (ttm)
$58.42M
Revenue Growth
+9.06%
P/S Ratio
1.42
Revenue / Employee
$274,291
Employees
213
Market Cap
82.69M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 202556.94M6.79M13.54%
Apr 30, 202450.16M-3.72M-6.90%
Apr 30, 202353.87M4.76M9.69%
Apr 30, 202249.11M8.07M19.66%
Apr 30, 202141.04M8.92M27.76%
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Verrica Pharmaceuticals 30.83M
Pelthos Therapeutics 7.41M
Pyxis Oncology 2.82M
Coeptis Therapeutics Holdings 501.00K
Seres Therapeutics 351.00K
aTyr Pharma 190.00K
Revenue Rankings

CSBR News

More News